Current Management for Late Normal Tissue Injury: Radiation-Induced Fibrosis and Necrosis

Seminars in Radiation Oncology

Volumn 17, Issue 2, 2007, Pages 99-107

  Delanian, Sylvie ^a   Lefaix, Jean Louis ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CAPTOPRIL; CLODRONIC ACID; COLCHICINE; GAMMA INTERFERON; HEPARIN; IBUPROFEN; LIPOSOMAL SUPEROXIDE DISMUTASE; LOSARTAN; PENICILLAMINE; PENTOXIFYLLINE; PLACEBO; PRAVASTATIN; PREDNISONE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG SPECIFICITY; DRUG TARGETING; FIBROSIS; HUMAN; HYPERBARIC OXYGEN; INFLAMMATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIATION HAZARD; RADIATION INJURY; RADIATION NECROSIS; RISK FACTOR; TREATMENT DURATION;

EID: 33947577419     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2006.11.006     Document Type: Article

References (93)

1. Delanian S., and Lefaix J.L. The radiation-induced fibroatrophic process: Therapeutic perspective via the antioxidant pathway. Radiother Oncol 73 (2004) 119-131
2. Delanian S., and Lefaix J.L. Mature bone necrosis: from recent pathophysiological aspects to a new therapeutic action. [in French]. Cancer Radiother 6 (2002) 1-9
3. Coleman N., Kelly L., Riese Daly N., et al. Phase II study of ibuprofen versus placebo for radiation-induced genitourinary side effects. Int J Radiat Oncol Biol Phys 54 (2002) 191-194
4. Geraci J., Mariano M., and Jackson K. Amelioration of radiation nephropathy in rats by dexamethasone treatment after irradiation. Radiat Res 134 (1993) 86-93
5. Evans M., Graham M., Mahler P., et al. Use of steroids to suppress vascular response to radiation. Int J Radiat Oncol Biol Phys 13 (1987) 563-567
6. Moulder J. Pharmacological intervention to prevent or ameliorate chronic radiation injuries. Semin Radiat Oncol 13 (2003) 73-84
7. Delattre J., Rosenblum M., Thaler H., et al. A model of radiation myelopathy in the rat. Pathology, regional capillary changes and treatment with dexamethasone. Brain 111 (1988) 1319-1336
8. Gross N., Narine K., and Wade R. Protective effect of corticosteroids on radiation pneumonitis in mice. Radiat Res 113 (1988) 112-119
9. Gross N., Holloway N., and Narine K. Effects of some nonsteroidal anti-inflammatory agents on experimental radiation pneumonitis. Radiat Res 127 (1991) 317-324
10. Abergel A., Darcha C., Chevallier M., et al. Histological response in patients treated by interferon plus ribavarin for hepatitis C virus-related severe fibrosis. Eur J Gastroenterol Hepatol 16 (2004) 1219-1227
11. Ziesche R., Hofbauer E., Wittman K., et al. A preliminary study of long term treatment with interferon gamma 1b and low dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 341 (1999) 1264-1269
12. Peter R., Gottlober P., Nadeshina N., et al. Interferon gamma in survivors of the Chernobyl power plant accident: new therapeutic option for radiation-induced fibrosis. Int J Radiat Oncol Biol Phys 45 (1999) 147-152
13. Gottlober P., Steinert M., Bahren W., et al. Interferon gamma in 5 patients with cutaneous radiation syndrome after radiation therapy. Int J Radiat Oncol Biol Phys 50 (2001) 159-166
14. Steen V., Medsger T., and Rodnan G. D-penicillamine therapy in progressive systemic sclerosis. Ann Int Med 97 (1982) 652-659
15. Rambaldi A., and Gluud C. Colchicine for alcoholic and non alcoholic liver fibrosis and cirrhosis. Cochrane Database Syst Rev 18 (2005) CD002148
16. Selman M., Carillo G., Salas J., et al. Colchicine, D-penicillamine, and prednisone in the treatment of idiopathic pulmonary fibrosis: A controlled clinical trial. Chest 114 (1998) 507-512
17. Entzian P., Schlaak M., Seitzer U., et al. Anti-inflammatory and antifibrotic properties of colchicine: Implications for idiopathic pulmonary fibrosis. Lung 175 (1997) 41-51
18. Samlaska C., and Winfield E. Pentoxifylline: Clinical review. J Am Acad Dematol 30 (1994) 603-621
19. Lefaix J.-L., Delanian S., Vozenin M.-C., et al. Striking regression of subcutaneous fibrosis induced by high doses of gamma rays using a combination of pentoxifylline and alpha-tocopherol: An experimental study. Int J Radiat Oncol Biol Phys 43 (1999) 839-847
20. Werner-Wasik M., and Madoc-Jones H. Trental (pentoxifylline) relives pain from postradiation fibrosis. Int J Radiat Oncol Biol Phys 25 (1993) 757-758
21. Futran N., Trotti A., and Gwede C. Pentoxifylline in the treatment of radiation-related soft tissue injury: Preliminary observations. Laryngoscope 107 (1997) 391-395
22. Okunieff P., Augustine E., Hicks J.E., et al. Pentoxifylline in the treatment of radiation-induced fibrosis. J Clin Oncol 22 (2004) 2207-2213
23. Chua D., Lo C., Yuen J., et al. A pilot study of pentoxifylline in the treatment of radiation-induced trismus. Am J Clin Oncol 24 (2001) 366-369
24. Delanian S., Porcher R., Balla-Mekias S., et al. Randomized placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J Clin Oncol 21 (2003) 2545-2550
25. Pasquier D., Hoelscher T., Schmutz J., et al. Hyperbaric oxygen therapy in the treatment of radio-induced lesions in normal tissues: A literature review. Radiother Oncol 72 (2004) 1-13
26. Carl U., Feldmeier J., Schmitt G., et al. Hyperbaric oxygen therapy for late sequelae in women receiving radiation after breast-conserving surgery. Int J Radiat Oncol Biol Phys 49 (2001) 1029-1031
27. Gothard L., Stanton A., McLaren J., et al. Non-randomised phase II trial of hyperbaric oxygen therapy in patients with chronic arm lymphedema and tissue fibrosis after radiotherapy for early breast cancer. Radiother Oncol 70 (2004) 217-224
28. Pritchard J., Anand P., Broome J., et al. Double-blind randomized phase II study of hyperbaric oxygen in patients with radiation-induced brachial plexopathy. Radiother Oncol 58 (2001) 279-286
29. Ward W., Molteni A., Ts'ao C., et al. Functional responses of the pulmonary endothelium to thoracic irradiation in rats: Differential modification by D-penicillamine. Int J Radiat Oncol Biol Phys 13 (1987) 1505-1509
30. Moulder J., Fish B., Regner K., et al. Angiotensin II blockade reduces radiation-induced proliferation in experimental radiation nephropathy. Radiat Res 157 (2002) 393-401
31. Moulder J. Pharmacological intervention to prevent or ameliorate chronic radiation injuries. Sem Radiat Oncol 13 (2003) 73-84
32. Cohen E., Hussain S., and Moulder J. Successful treatment of radiation nephropathy with angiotensin II blockade. Int J Radiat Oncol Biol Phys 55 (2003) 190-193
33. Haydont V., Mathe D., Bourgier C., et al. Induction of CTGF by TGFb1 in normal and radiation enteritis human smooth muscle cells: Smad/rho balance and therapeutic perspectives. Radiother Oncol 76 (2005) 219-225
34. Hauer-Jensen M., Fort C., Mehta J., et al. Influence of statins on postoperative wound complications after inguinal or ventral herniorrhaphy. Hernia 10 (2006) 48-52
35. Wang J., Zheng H., Qiu X., et al. Modulation of the intestinal response to ionizing radiation by anticoagulant and non anticoagulant heparins. Thromb Haemost 94 (2005) 1054-1059
36. Michelson A. Medical Aspects of Superoxide Dismutase. Life Chemistry Reports (1987), Harwood Academic Publishers, United Kingdom 1-142
37. Niwa Y., Somiya K., Michelson A., et al. Effect of liposomal-encapsulated superoxide dismutase on active oxygen-related human disorders. A preliminary study. Free Radic Res Commun 1 (1985) 137-153
38. Emerit J., Michelson A., Robert H., et al. Treatment with superoxide dismutase of two cases of radiation-induced sclerosis. [in French]. Sem Hop 59 (1983) 277-281
39. Delanian S., Baillet F., Huart J., et al. Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase: Clinical trial. Radiother Oncol 32 (1994) 12-20
40. Lefaix J.-L., Delanian S., Leplat J.-J., et al. Successful treatment of radiation-induced fibrosis using Cu/Zn-SOD and Mn-SOD: An experimental study. Int J Radiat Oncol Biol Phys 35 (1996) 305-312
41. Benyahia B., Campana F., Perdereau B., et al. The effects of superoxide dismutase topical treatment on human skin radiofibrosis: A pathological study. Breast 5 (1996) 75-81
42. Campana F., Zervoudis S., Perdereau B., et al. Topical superoxide dismutase reduces post-irradiation breast cancer fibrosis. J Cell Mol Med 8 (2004) 109-116
43. Delanian S., Bravard A., Martin M., et al. In vitro modulation by liposomal superoxide dismutase of the fibroblast phenotype in human skin with chronic radiotherapy damage. Radiother Oncol 58 (2001) 325-331
44. Vozenin-Brotons M.-C., Sivan V., Gault N., et al. Anti-fibrotic action of Cu/Zn SOD is mediated by TGF-β1 repression and phenotypic reversion of myofibroblasts. Free Radic Biol Med 30 (2001) 30-42
45. Nielsen O., Overgaard J., Overgaard M., et al. Orgotein in radiation treatment of bladder cancer. A report on allergic reactions and lack of radioprotective effect. Acta Oncol 26 (1987) 101-104
46. Sanchy F., Milla A., Artola N., et al. Prevention of radiation-induced cystitis by orgotein: A randomized study. Anticancer Res 16 (1996) 2025-2028
47. Vujaskovic Z., Batanic-Haberle I., Rabbani Z., et al. A small molecular weight catalytic metalloporphyrin antioxidant with superoxide dismutase mimetic properties protects lungs from radiation-induced injury. Free Radic Biol Med 33 (2002) 857-863
48. Rabbani Z., Anscher M., Folz R., et al. Overexpression of extracellular superoxide dismutase reduces acute radiation-induced lung toxicity. BMC Cancer 5 (2005) 59-72
49. Epperly M., Epstein C., Travis E., et al. Decreased pulmonary radiation resistance of manganese superoxide dismutase (MnSOD)-deficient mice is corrected by human manganese superoxide dismutase-plasmid/liposome (SOD2-PL) intratracheal gene therapy. Radiat Res 154 (2000) 365-374
50. Lamproglu I., Magdelenat H., Boisserie G., et al. An experimental model of acute encephalopathy after total body irradiation in the rat: Effect of liposome entrapped Cu/Zn SOD. Int J Radiat Oncol Biol Phys 42 (1998) 179-184
51. Molla M., Gironella M., Salas A., et al. Protective effect of superoxide dismutase in radiation-induced intestinal inflammation. Int J Radiat Oncol Biol Phys 61 (2005) 1159-1166
52. Packer L., Weber S., and Rimbach G. Molecular aspects of alpha-tocopherol antioxidant action and cell signaling. J Nutr 131 (2001) 369S-373S
53. Azzi A., Ricciarelli R., and Zingg J.-M. Non-oxidant molecular functions of alpha-tocopherol (vitamin E): Minireview. FEBS Lett 519 (2002) 8-10
54. Baillet F. Alpha-tocopherol treatment of radiofibrosis post-brachytherapy for breast cancer. Radiother Oncol 43 suppl 1 (1997) S3 (, abstr)
55. Ferreira P., Fleck J., Diehl A., et al. Protective effect of alpha tocopherol in head neck cancer radiation-induced mucositis: A double blind randomized trial. Head Neck 26 (2004) 313-321
56. Eidelman R., Hollar D., Hebert P., et al. Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Arch Intern Med 164 (2004) 1552-1556
57. Miller E., Pastor-Bariuso R., Dalal D., et al. Meta-analysis: high dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142 (2005) 37-46
58. Bowry V., and Stocker R. Tocopherol-mediated peroxidation: The prooxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein. J Am Chem Soc 115 (1993) 6029-6044
59. Delanian S. Striking regression of radiation-induced fibrosis by a combination of pentoxifylline and tocopherol (case report). Br J Radiol 71 (1998) 892-894
60. Delanian S., Balla-Mekias S., and Lefaix J.-L. Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol. J Clin Oncol 17 (1999) 3283-3290
61. Delanian S., Porcher R., Rudant J., et al. Kinetics of response to long term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis. J Clin Oncol 23 (2005) 8570-8579
62. Haddad P., Kalaghchi B., and Amouzegar-Hashemi F. Pentoxifylline and Vitamin E combination for superficial radiation-induced fibrosis: A phase II clinical trial. Radiother Oncol 77 (2005) 324-326
63. Cosset J.-M. Breur Gold Medal Award Lecture 2001: Irradiation accidents lessons for oncology. Radiother Oncol 63 (2002) 1-10
64. Gothard L., Cornes P., Earl J., et al. Double blind placebo-controlled randomized trial of vitamin E and pentoxifylline in patients with chronic arm lymphedema and fibrosis after surgery and radiotherapy for breast cancer. Radiother Oncol 73 (2004) 133-139
65. Georges C., Delanian S., and Lefaix J.-L. Resolution of progressive failed back surgery syndrome with a striking reduction of epidural fibrosis using combined pentoxifylline and tocopherol. Br J Radiol 77 (2004) 885-887
66. Hille A., Christiansen H., Pradier O., et al. Effect of pentoxifylline and tocopherol on radiation proctitis/ enteritis. Strahlenther Onkol 181 (2005) 606-614
67. Gothard L., Cornes P., Brooker S., et al. Phase II study of vitamin E and pentoxifylline in patients with late side effects of pelvic radiotherapy. Radiother Oncol 75 (2005) 334-341
68. Letur-Könirsch H., Guis F., and Delanian S. Major uterine restoration by radiation sequelae regression with a combination of pentoxifylline- tocopherol: A phase II study. Fertil Steril 77 (2002) 1219-1226
69. Ledee-Bataille N., Olivennes F., Lefaix J.-L., et al. Combined treatment by pentoxifylline and tocopherol for recipient women with a thin endometrium enrolled in an oocyte donation program. Hum Reprod 17 (2002) 1249-1253
70. Laurent C., Pouget J.-P., and Voisin P. Modulation of DNA damage by pentoxifylline and alpha-tocopherol in skin fibroblasts exposed to gamma-rays. Radiat Res 164 (2005) 63-72
71. Laurent C., Voisin P., and Pouget J.-P. DNA damage in cultured skin microvascular endothelial cells exposed to gamma rays and treated by the combination pentoxifylline and alpha-tocopherol. Int J Radiat Biol 82 (2006) 309-321
72. Rodan G., and Fleisch A. Biphosphonates: Mechanisms of action. J Clin Invest 97 (1996) 2692-2696
73. Dunn C., Galinat L., Wu H., et al. Demonstration of novel antiarthritic and anti-inflammatory effects of diphosphonates. J Pharmacol Exp Ther 226 (1993) 1691-1698
74. Ruggiero S., Mehrotra B., Rosenberg T., et al. osteonecrosis of the jaws associated with the use of biphosphonates: A review of 63 cases. J Oral Maxillofac Surg 62 (2004) 527-534
75. Fromigue O., and Body J. Biphosphonates influence the proliferation and the maturation of normal human osteoblasts. J Endocrinol Invest 25 (2002) 539-546
76. Atula S., Powles T., Paterson A., et al. Extended safety profile of oral clodronate after long term use in primary breast cancer patients. Drug Saf 26 (2003) 661-671
77. McCloskey E., Selby P., Davies M., et al. Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: Results of a double blind placebo-controlled 3-year study. J Bone Miner Res 19 (2004) 728-736
78. Johnston C., Williams J., Elder A., et al. Inflammatory cell recruitment following thoracic irradiation. Exp Lung Res 30 (2004) 369-382
79. Diel I., Solomayer E., Costa S., et al. Reduction in new metastasis in breast cancer with adjuvant clodronate treatment. N Engl J Med 6 (1998) 357-363
80. Froom P., Elmalah I., Braester A., et al. Clodronate in myelofibrosis: A case report. Am J Med Sci 323 (2002) 115-116
81. Tibbles P., and Edelsberg J. Hyperbaric-oxygen therapy. Review article. N Engl J Med 334 (1996) 1642-1648
82. Delanian S., Depondt J., and Lefaix J.-L. Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: a phase II trial. Head Neck 27 (2005) 114-123
83. Annane D., Depondt J., Aubert P., et al. Hyperbaric oxygen therapy for radionecrosis of the jaw: A randomized placebo-controlled, double blind, trial from the ORN96 Study Group. J Clin Oncol 22 (2004) 4893-4900
84. Marx R., and Johnson R. Studies in the radiobiology of osteoradionecrosis and their clinical significance. Oral Surg Oral Med Oral Pathol 64 (1987) 379-390
85. Bennett M., Feldmeier J., Hampson N., et al. Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database Syst Rev 20 (2005) CD005005
86. Mayer R., Klemen H., Quehenberger F., et al. Hyperbaric oxygen: An effective tool to treat radiation morbidity in prostate cancer. Radiother Oncol 61 (2001) 151-156
87. Gouello J.P., Bouachour G., Person B., et al. Contribution of hyperbaric oxygen in radiation-induced digestive disorders: 36 observations. Presse Med 28 (1999) 1053-1057
88. Corman J., McClure D., Pritchett R., et al. Treatment of radiation-induced hemorrhagic cystitis with hyperbaric oxygen. J Urol 169 (2003) 2200-2202
89. Bevers R., Bakker D., and Kurth K. Hyperbaric oxygen treatment for haemorrhagic radiation cystitis. Lancet 346 (1995) 803-805
90. Dion M., Hussey D., Doornbos J., et al. Preliminary study of pentoxifylline in the treatment of late radiation soft tissue necrosis. Int J Radiat Oncol Biol Phys 19 (1990) 401-407
91. Fischer M., Wohlrab J., and Marsch W. Crux medicorum ulcerated radiation-induced fibrosis successful therapy with pentoxifylline and vitamin E (case report). Eur J Dermatol 11 (2001) 38-40
92. Delanian S., and Lefaix J.-L. Complete healing of severe osteoradionecrosis by treatment combining pentoxifylline, tocopherol and Clodronate (case report). Br J Radiol 75 (2002) 467-469
93. Delanian S., Pradat P.-F., Maisonobe T., et al. New data in the treatment of radiation-induced plexitis (in French) (2005) Presented at the meeting of Société Française de Neurologie. Paris La Villette, France, December 2